Published in Am J Obstet Gynecol on June 01, 2002
Women's Health Initiative (WHI) | NCT00000611
Video Decision Aid in Latina Women With Pelvic Organ Prolapse | NCT02850835
Host Response to Pessaries in Microbial Communities of the Postmenopausal Vagina | NCT02605135
Adverse Childhood Experiences in Urogynecologic Patients (ACE-UP) | NCT03480477
Prevalence of symptomatic pelvic floor disorders in US women. JAMA (2008) 7.81
The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int (2015) 3.12
Incidence and lifetime risk of pelvic organ prolapse surgery in Denmark from 1977 to 2009. Int Urogynecol J (2014) 2.16
Prevalence & factors associated with chronic obstetric morbidities in Nashik district, Maharashtra. Indian J Med Res (2015) 2.06
Lifetime risk of surgical management for pelvic organ prolapse or urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.96
Interaction among apical support, levator ani impairment, and anterior vaginal wall prolapse. Obstet Gynecol (2006) 1.91
Outcomes of vaginal prolapse surgery among female Medicare beneficiaries: the role of apical support. Obstet Gynecol (2013) 1.88
Childbirth and pelvic floor dysfunction: an epidemiologic approach to the assessment of prevention opportunities at delivery. Am J Obstet Gynecol (2006) 1.77
Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J (2013) 1.76
Severity of pelvic organ prolapse associated with measurements of pelvic floor function. Int Urogynecol J Pelvic Floor Dysfunct (2005) 1.74
Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol (2014) 1.70
Incidence of pelvic floor repair after hysterectomy: A population-based cohort study. Am J Obstet Gynecol (2007) 1.56
Failure of elastic fiber homeostasis leads to pelvic floor disorders. Am J Pathol (2006) 1.55
Anterior vaginal wall length and degree of anterior compartment prolapse seen on dynamic MRI. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.54
Can pelvic floor injury secondary to delivery be prevented? Int Urogynecol J (2011) 1.46
Anterior vaginal wall prolapse and voiding dysfunction in urogynecology patients. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.45
Genetics of pelvic organ prolapse: crossing the bridge between bench and bedside in urogynecologic research. Int Urogynecol J (2011) 1.41
A 3D finite element model of anterior vaginal wall support to evaluate mechanisms underlying cystocele formation. J Biomech (2009) 1.38
Racial differences in pelvic organ prolapse. Obstet Gynecol (2009) 1.30
Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.30
Gastrointestinal complications following abdominal sacrocolpopexy for advanced pelvic organ prolapse. Am J Obstet Gynecol (2007) 1.29
Avulsion of puborectalis muscle and other risk factors for cystocele recurrence: a 2-year follow-up study. Int Urogynecol J (2011) 1.29
Vaginal tactile imaging. IEEE Trans Biomed Eng (2010) 1.26
Incidence of recurrent pelvic organ prolapse 10 years following primary surgical management: a retrospective cohort study. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.20
Distribution of pelvic organ support measures in a population-based sample of middle-aged, community-dwelling African American and white women in southeastern Michigan. Am J Obstet Gynecol (2008) 1.18
Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol (2008) 1.17
Symptomatic pelvic organ prolapse at midlife, quality of life, and risk factors. Obstet Gynecol (2009) 1.16
Racial differences in pelvic anatomy by magnetic resonance imaging. Obstet Gynecol (2008) 1.15
Pelvic organ prolapse: demographics and future growth prospects. Int Urogynecol J Pelvic Floor Dysfunct (2006) 1.14
Risk factors for the recurrence of pelvic organ prolapse after vaginal surgery: a review at 5 years after surgery. Int Urogynecol J Pelvic Floor Dysfunct (2007) 1.11
Pelvic organ support among primiparous women in the first year after childbirth. Int Urogynecol J Pelvic Floor Dysfunct (2009) 1.10
The aetiology of prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.09
Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.08
Development of a wireless intra-vaginal transducer for monitoring intra-abdominal pressure in women. Biomed Microdevices (2012) 1.08
Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol (2009) 1.05
Comparison between trans-obturator trans-vaginal mesh and traditional anterior colporrhaphy in the treatment of anterior vaginal wall prolapse: results of a French RCT. Int Urogynecol J (2013) 1.01
Anatomy and histology of apical support: a literature review concerning cardinal and uterosacral ligaments. Int Urogynecol J (2012) 1.00
Animal models of female pelvic organ prolapse: lessons learned. Expert Rev Obstet Gynecol (2012) 1.00
Ethnicity and variations of pelvic organ prolapse bother. Int Urogynecol J (2013) 1.00
Family history as a risk factor for pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.99
Correlates of sexual satisfaction among sexually active postmenopausal women in the Women's Health Initiative-Observational Study. J Gen Intern Med (2008) 0.99
Vaginal pressure during lifting, floor exercises, jogging, and use of hydraulic exercise machines. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.98
Exploring the association between lifetime physical activity and pelvic floor disorders: study and design challenges. Contemp Clin Trials (2012) 0.98
Efficacy of a standardized technique of trans-vaginal entry into the peritoneal cavity for post-hysterectomy vaginal vault suspension. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.96
A long-term treatment outcome of abdominal sacrocolpopexy. Yonsei Med J (2009) 0.96
Porcine subintestinal submucosal graft augmentation for rectocele repair: a randomized controlled trial. Obstet Gynecol (2012) 0.96
The length of anterior vaginal wall exposed to external pressure on maximal straining MRI: relationship to urogenital hiatus diameter, and apical and bladder location. Int Urogynecol J (2014) 0.95
Risk factors for pelvic floor repair after hysterectomy. Obstet Gynecol (2009) 0.95
Changing trends of surgical approaches for uterine prolapse: an 11-year population-based nationwide descriptive study. Int Urogynecol J (2012) 0.94
Uterine prolapse. BMJ (2007) 0.94
Clinical challenges in the management of vaginal prolapse. Int J Womens Health (2014) 0.94
Hormones restore biomechanical properties of the vagina and supportive tissues after surgical menopause in young rats. Am J Obstet Gynecol (2008) 0.93
Spanish language translation of pelvic floor disorders instruments. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.92
Evolution of the female pelvis and relationships to pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2005) 0.90
COL1A1 Sp1-binding site polymorphism as a risk factor for genital prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.90
Physical activity in women planning sacrocolpopexy. Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.90
Types of pelvic floor dysfunctions in nulliparous, vaginal delivery, and cesarean section female patients with obstructed defecation syndrome identified by echodefecography. Int J Colorectal Dis (2009) 0.90
Surgery for posterior vaginal wall prolapse. Int Urogynecol J (2013) 0.89
Quantification of pelvic organ prolapse in mice: vaginal protease activity precedes increased MOPQ scores in fibulin 5 knockout mice. Biol Reprod (2008) 0.89
Urinary incontinence in community-dwelling older Mexican American and European American women. Arch Gerontol Geriatr (2008) 0.89
The use of transvaginal synthetic mesh for anterior vaginal wall prolapse repair: a randomized controlled trial. Int Urogynecol J (2013) 0.88
Rectocele and intussusception: is there any coherence in symptoms or additional pelvic floor disorders? Tech Coloproctol (2009) 0.88
Genetic epidemiology of pelvic organ prolapse: a systematic review. Am J Obstet Gynecol (2014) 0.88
A systematic review of clinical studies on hereditary factors in pelvic organ prolapse. Int Urogynecol J (2012) 0.88
LOX family enzymes expression in vaginal tissue of premenopausal women with severe pelvic organ prolapse. Int Urogynecol J (2010) 0.87
Risk factors for prolapse development in white, black, and Hispanic women. Female Pelvic Med Reconstr Surg (2011) 0.87
Intra-abdominal pressures during activity in women using an intra-vaginal pressure transducer. J Sports Sci (2014) 0.87
Urinary incontinence, fecal incontinence and pelvic organ prolapse in a population-based, racially diverse cohort: prevalence and risk factors. Female Pelvic Med Reconstr Surg (2010) 0.87
Is laminin gamma-1 a candidate gene for advanced pelvic organ prolapse? Am J Obstet Gynecol (2010) 0.86
Depression among women with obstetric fistula, and pelvic organ prolapse in northwest Ethiopia. BMC Psychiatry (2013) 0.86
Chinese validation of Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Int Urogynecol J (2011) 0.86
Comprehensive analysis of LAMC1 genetic variants in advanced pelvic organ prolapse. Am J Obstet Gynecol (2012) 0.86
Primary versus recurrent prolapse surgery: differences in outcomes. Int Urogynecol J (2009) 0.85
Phenotyping clinical disorders: lessons learned from pelvic organ prolapse. Am J Obstet Gynecol (2012) 0.85
Prolapse symptoms in overweight and obese women before and after weight loss. Female Pelvic Med Reconstr Surg (2012) 0.85
Vaginal support as determined by levator ani defect status 6 weeks after primary surgery for pelvic organ prolapse. Int J Gynaecol Obstet (2011) 0.85
Lower exposure rates of partially absorbable mesh compared to nonabsorbable mesh for cystocele treatment: 3-year follow-up of a prospective randomized trial. Int Urogynecol J (2012) 0.85
Estrogen alters remodeling of the vaginal wall after surgical injury in guinea pigs. Biol Reprod (2013) 0.85
Trocarless system for mesh attachment in pelvic organ prolapse repair--1-year evaluation. Int Urogynecol J (2011) 0.85
Colorectal and anal symptoms in women with urinary incontinence and pelvic organ prolapse. Int Urogynecol J (2009) 0.85
Midline uterosacral plication anterior colporrhaphy combo (MUSPACC): preliminary surgical report. Int Urogynecol J (2010) 0.85
Pelvic organ prolapse and stress urinary incontinence: A review of etiological factors. Indian J Urol (2007) 0.84
Vaginal parity and pelvic organ prolapse. J Reprod Med (2010) 0.84
Utilization of surgical procedures for pelvic organ prolapse: a population-based study in Olmsted County, Minnesota, 1965-2002. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.84
Vitamin D status: a review with implications for the pelvic floor. Int Urogynecol J (2012) 0.83
In vivo assessment of anterior compartment compliance and its relation to prolapse. Int Urogynecol J (2010) 0.83
Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse. Obstet Gynecol (2012) 0.83
Pregnancy After a Laparoscopic Sacrohysteropexy: a Case Report. Geburtshilfe Frauenheilkd (2014) 0.83
Effect of vaginal or systemic estrogen on dynamics of collagen assembly in the rat vaginal wall. Biol Reprod (2014) 0.83
Pelvic Organ Prolapse-Associated Cystitis. Curr Bladder Dysfunct Rep (2014) 0.83
Surgical outcomes of anterior trans-obturator mesh and vaginal sacrospinous ligament fixation for severe pelvic organ prolapse in overweight and obese Asian women. Int Urogynecol J (2012) 0.83
Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17. Am J Obstet Gynecol (2014) 0.83
An insight into pelvic floor status in nulliparous women. Int Urogynecol J (2013) 0.82
Does traction on the cervix under anaesthesia tell us when to perform a concomitant hysterectomy? A 2-year follow-up of a prospective cohort study. Int Urogynecol J (2014) 0.82
Obesity and outcomes after sacrocolpopexy. Am J Obstet Gynecol (2008) 0.82
The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse. Int Urogynecol J (2010) 0.82
Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse. Menopause (2011) 0.82
Clinical-decision taking in primary pelvic organ prolapse; the effects of diagnostic tests on treatment selection in comparison with a consensus meeting. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.82
Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J (2013) 0.81
A multi-compartment 3-D finite element model of rectocele and its interaction with cystocele. J Biomech (2015) 0.81
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA (2003) 10.61
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med (2011) 8.19
Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95
Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med (2006) 7.42
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73
Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst (2005) 5.52
Effects of estrogen with and without progestin on urinary incontinence. JAMA (2005) 5.41
Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA (2003) 5.26
Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol (2010) 4.78
American Cancer Society Guidelines on Nutrition and Physical Activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2006) 4.69
A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59
Weight loss in breast cancer patient management. J Clin Oncol (2002) 4.51
Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42
Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst (2012) 3.87
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin (2006) 3.67
Depression and cardiovascular sequelae in postmenopausal women. The Women's Health Initiative (WHI). Arch Intern Med (2004) 3.59
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58
Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53
Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47
Defining success after surgery for pelvic organ prolapse. Obstet Gynecol (2009) 3.46
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27
Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity, and Lifestyle (HEAL) study. Cancer (2003) 3.25
Effect of exercise on total and intra-abdominal body fat in postmenopausal women: a randomized controlled trial. JAMA (2003) 3.22
Oral bisphosphonate use and breast cancer incidence in postmenopausal women. J Clin Oncol (2010) 3.17
Randomized controlled trial of biofeedback, sham feedback, and standard therapy for dyssynergic defecation. Clin Gastroenterol Hepatol (2007) 3.16
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol (2008) 3.05
A midurethral sling to reduce incontinence after vaginal prolapse repair. N Engl J Med (2012) 2.90
Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA (2004) 2.90
Physical activity levels among breast cancer survivors. Med Sci Sports Exerc (2004) 2.88
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol (2008) 2.85
Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst (2011) 2.84
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol (2008) 2.79
Physical activity and survival in postmenopausal women with breast cancer: results from the women's health initiative. Cancer Prev Res (Phila) (2011) 2.73
The collaboration readiness of transdisciplinary research teams and centers findings from the National Cancer Institute's TREC Year-One evaluation study. Am J Prev Med (2008) 2.64
Two-year outcomes after sacrocolpopexy with and without burch to prevent stress urinary incontinence. Obstet Gynecol (2008) 2.58
Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med (2009) 2.54
Moderate-intensity exercise reduces the incidence of colds among postmenopausal women. Am J Med (2006) 2.53
Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause (2010) 2.50
Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res (2003) 2.49
Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation (2006) 2.40
Fecal and urinary incontinence in primiparous women. Obstet Gynecol (2006) 2.28
Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J Clin Oncol (2010) 2.26
Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr (2006) 2.25
Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med (2005) 2.17
Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity (Silver Spring) (2011) 2.08
Anticholinergic therapy vs. onabotulinumtoxina for urgency urinary incontinence. N Engl J Med (2012) 2.03
Abdominal pain, bloating, and urgency. Obstet Gynecol (2005) 2.02
Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors. J Clin Oncol (2005) 2.01
Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol (2005) 2.01
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. J Clin Oncol (2010) 2.00
Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause (2004) 1.97
Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med (2008) 1.94
A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods. Control Clin Trials (2003) 1.93
Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation. Cancer (2008) 1.90
Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med (2011) 1.90
Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med (2010) 1.88
American Cancer Society guidelines on nutrition and physical activity for cancer prevention: Reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin (2002) 1.88
Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol (2008) 1.85
Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors. Breast Cancer Res Treat (2007) 1.84
Significance testing for small microarray experiments. Stat Med (2005) 1.80
Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. J Natl Cancer Inst (2013) 1.80
The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev (2012) 1.75
Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med (2007) 1.75
The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol (2009) 1.73
Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst (2008) 1.72
Statin use and breast cancer: prospective results from the Women's Health Initiative. J Natl Cancer Inst (2006) 1.70
Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat (2008) 1.69
Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.67
Fasting C-peptide levels and death resulting from all causes and breast cancer: the health, eating, activity, and lifestyle study. J Clin Oncol (2010) 1.66
Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: randomized controlled trial. J Clin Oncol (2012) 1.66
The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J Pelvic Floor Dysfunct (2008) 1.64
Urinary bacteria in adult women with urgency urinary incontinence. Int Urogynecol J (2014) 1.61
Frequent intentional weight loss is associated with lower natural killer cell cytotoxicity in postmenopausal women: possible long-term immune effects. J Am Diet Assoc (2004) 1.61
Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors. Breast Cancer Res Treat (2008) 1.60
Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2005) 1.56
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Med (2011) 1.55
The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics and quality of life. J Urol (2009) 1.55
Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urol (2011) 1.53
Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res (2012) 1.50
Shorter telomeres associate with a reduced risk of melanoma development. Cancer Res (2011) 1.49
Factors associated with objective (actigraphic) and subjective sleep quality in young adult women. J Psychosom Res (2005) 1.47
Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause (2010) 1.47
Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst (2009) 1.47
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens (2014) 1.45
History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women. Metabolism (2012) 1.43
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr (2008) 1.41
Flushing and papules in a middle-aged woman. Obstet Gynecol (2005) 1.38
Proceedings of the National Institute of Diabetes and Digestive and Kidney Diseases International Symposium on Epidemiologic Issues in Urinary Incontinence in Women. Am J Obstet Gynecol (2003) 1.37
Effects of exercise on metabolic risk variables in overweight postmenopausal women: a randomized clinical trial. Obes Res (2005) 1.37
Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev (2004) 1.35
Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. J Clin Oncol (2009) 1.35
Incidence and survival of malignant bone sarcomas in England 1979-2007. Int J Cancer (2011) 1.34
Mesh erosion in robotic sacrocolpopexy. Female Pelvic Med Reconstr Surg (2012) 1.34
Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report. Qual Life Res (2007) 1.33
A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control (2003) 1.31
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas (2006) 1.31